Gene Therapy for Chronic Pain

作者: William R. Lariviere , Doris K. Cope

DOI: 10.1007/978-0-387-78323-9_19

关键词:

摘要: Gene therapy shows great potential to assist numerous patients with inadequate relief of inflammatory or neuropathic pain, intractable pain associated advanced cancer. A brief overview is provided the methods gene and preclinical findings in animal models prolonged inflammatory, cancer pain. Preclinical demonstrate no efficacy on basal thermal nociception mechanical sensitivity, almost universal effects pathological hypersensitivity models. The status human trials recommendations for future directions precautions. This early stage development chronic will likely be followed by an increased number clinical aimed specifically at chronic, unrelenting

参考文章(62)
Jens Kurreck, Antisense and RNA interference approaches to target validation in pain research. Current Opinion in Drug Discovery & Development. ,vol. 7, pp. 179- ,(2004)
Maria Castro, Andres Hurtado-Lorenzo, Pablo Umana, Joseph R. Smith-Arica, Adam Zermansky, Evely Abordo-Adesida, Pedro R. Löwenstein, Regulatable and cell-type specific transgene expression in glial cells: prospects for gene therapy for neurological disorders. Progress in Brain Research. ,vol. 132, pp. 655- 681 ,(2001) , 10.1016/S0079-6123(01)32109-X
Jun Liu, Darren Wolfe, Shuanglin Hao, Shaohua Huang, Joseph C. Glorioso, Marina Mata, David J. Fink, Peripherally delivered glutamic acid decarboxylase gene therapy for spinal cord injury pain Molecular Therapy. ,vol. 10, pp. 57- 66 ,(2005) , 10.1016/J.YMTHE.2004.04.017
Shuanglin Hao, Marina Mata, Joseph C Glorioso, David J Fink, HSV-mediated expression of interleukin-4 in dorsal root ganglion neurons reduces neuropathic pain. Molecular Pain. ,vol. 2, pp. 6- 6 ,(2006) , 10.1186/1744-8069-2-6
Svend O Freytag, Mark Khil, Hans Stricker, James Peabody, Mani Menon, Mariza DePeralta-Venturina, Daniel Nafziger, Jan Pegg, Dell Paielli, Steve Brown, Ken Barton, Mei Lu, Estuardo Aguilar-Cordova, Jae Ho Kim, None, Phase I Study of Replication-competent Adenovirus-mediated Double Suicide Gene Therapy for the Treatment of Locally Recurrent Prostate Cancer Cancer Research. ,vol. 62, pp. 4968- 4976 ,(2002)
STEVEN P. WILSON, DAVID C. YEOMANS, Virally mediated delivery of enkephalin and other neuropeptide transgenes in experimental pain models. Annals of the New York Academy of Sciences. ,vol. 971, pp. 515- 521 ,(2002) , 10.1111/J.1749-6632.2002.TB04516.X
Pierre-François Pradat, Françoise Finiels, Philippe Kennel, Souad Naimi, Cécile Orsini, Pia Delaere, Frédéric Revah, Jacques Mallet, Partial prevention of cisplatin-induced neuropathy by electroporation-mediated nonviral gene transfer. Human Gene Therapy. ,vol. 12, pp. 367- 375 ,(2001) , 10.1089/10430340150503993
M.-Z. Yao, J.-F. Gu, J.-H. Wang, L.-Y. Sun, M.-F. Lang, J. Liu, Z.-Q. Zhao, X.-Y. Liu, Interleukin-2 gene therapy of chronic neuropathic pain Neuroscience. ,vol. 112, pp. 409- 416 ,(2002) , 10.1016/S0306-4522(02)00078-7
Alan A. Finegold, Andrew J. Mannes, Michael J. Iadarola, A paracrine paradigm for in vivo gene therapy in the central nervous system: treatment of chronic pain. Human Gene Therapy. ,vol. 10, pp. 1251- 1257 ,(1999) , 10.1089/10430349950018238
JOHN P. REILLY, MARK A. GRISE, F. DAVID FORTUIN, PETER R. VALE, GARY L. SCHAER, JOHN LOPEZ, JOSEPH R. VAN CAMP, TIMOTHY HENRY, WAYNE E. RICHENBACHER, DOUGLAS W. LOSORDO, RICHARD A. SCHATZ, JEFFREY M. ISNER, Long-Term (2-Year) Clinical Events Following Transthoracic Intramyocardial Gene Transfer of VEGF-2 in No-Option Patients Journal of Interventional Cardiology. ,vol. 18, pp. 27- 31 ,(2005) , 10.1111/J.1540-8183.2005.04026.X